Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2113205

OTC Pharmaceuticals in Australia

Description:
Introduction

OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Australia otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.

- The Australian OTC pharmaceuticals market had total revenues of $3,701.2m in 2012, representing a compound annual growth rate (CAGR) of 3.9% between 2008 and 2012.

- The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $1,300.8m, equivalent to 35.1% of the market's overall value

- The performance of the market is forecast to follow the similar pattern with an anticipated CARC of 3.8% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $4,463.1m by the end of 2017.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Australia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Australia

Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Australia otc pharmaceuticals market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Australia economy

Key Questions Answered

What was the size of the Australia otc pharmaceuticals market by value in 2012?

What will be the size of the Australia otc pharmaceuticals market in 2017?

What factors are affecting the strength of competition in the Australia otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Australia's otc pharmaceuticals market?
 
Contents:
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
GlaxoSmithKline Plc
Johnson & Johnson
Reckitt Benckiser Group plc
Suntory Group
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations

LIST OF TABLES
Table 1: Australia OTC pharmaceuticals market value: $ million, 2008–12
Table 2: Australia OTC pharmaceuticals market category segmentation: $ million, 2012
Table 3: Australia OTC pharmaceuticals market geography segmentation: $ million, 2012
Table 4: Australia OTC pharmaceuticals market share: % share, by value, 2012
Table 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2012
Table 6: Australia OTC pharmaceuticals market value forecast: $ million, 2012–17
Table 7: GlaxoSmithKline Plc: key facts
Table 8: GlaxoSmithKline Plc: key financials ($)
Table 9: GlaxoSmithKline Plc: key financials (£)
Table 10: GlaxoSmithKline Plc: key financial ratios
Table 11: Johnson & Johnson: key facts
Table 12: Johnson & Johnson: key financials ($)
Table 13: Johnson & Johnson: key financial ratios
Table 14: Reckitt Benckiser Group plc: key facts
Table 15: Reckitt Benckiser Group plc: key financials ($)
Table 16: Reckitt Benckiser Group plc: key financials (£)
Table 17: Reckitt Benckiser Group plc: key financial ratios
Table 18: Suntory Group: key facts
Table 19: Suntory Group: key financials ($)
Table 20: Suntory Group: key financials (¥)
Table 21: Suntory Group: key financial ratios
Table 22: Australia size of population (million), 2008–12
Table 23: Australia gdp (constant 2000 prices, $ billion), 2008–12
Table 24: Australia gdp (current prices, $ billion), 2008–12
Table 25: Australia inflation, 2008–12
Table 26: Australia consumer price index (absolute), 2008–12
Table 27: Australia exchange rate, 2008–12

LIST OF FIGURES
Figure 1: Australia OTC pharmaceuticals market value: $ million, 2008–12
Figure 2: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2012
Figure 3: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2012
Figure 4: Australia OTC pharmaceuticals market share: % share, by value, 2012
Figure 5: Australia OTC pharmaceuticals market distribution: % share, by value, 2012
Figure 6: Australia OTC pharmaceuticals market value forecast: $ million, 2012–17
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Australia, 2012
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2012
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2012
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2012
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2012
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2012
Figure 13: GlaxoSmithKline Plc: revenues & profitability
Figure 14: GlaxoSmithKline Plc: assets & liabilities
Figure 15: Johnson & Johnson: revenues & profitability
Figure 16: Johnson & Johnson: assets & liabilities
Figure 17: Reckitt Benckiser Group plc: revenues & profitability
Figure 18: Reckitt Benckiser Group plc: assets & liabilities
Figure 19: Suntory Group: revenues & profitability
Figure 20: Suntory Group: assets & liabilities
 
Companies Mentioned
GlaxoSmithKline Plc, Johnson & Johnson, Reckitt Benckiser Group plc and Suntory Group
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2113205

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Sep 15th 2014
5:57:30 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

OTC Pharmaceuticals in Australia

Web Address

http://www.researchandmarkets.com/reports/2113205

Office Code

OCGOOGLE

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 350
Electronic (PDF) - Enterprisewide USD 875

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Sep 15th 2014
5:57:30 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)